What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?

Core Insights - Pfizer and Novo Nordisk are engaged in a competitive bidding process for the biotech firm Metsera, indicating a strategic move to enhance their product offerings in the rapidly growing weight-loss drug market [1] Company Strategies - Both Pfizer and Novo Nordisk are looking to expand their drug pipelines, particularly in the lucrative sector of weight-loss medications, which has seen significant growth recently [1]